APTENSIO XR FDA approval date
The FDA approved APTENSIO XR on 17 Apr 2015.
- FDA approval date
- 17 Apr 2015
- Source
- FDA record
Drug identity has not yet been verified against registry records
Also recorded as METHYLPHENIDATE HYDROCHLORIDE
Included trials
No linked trials for this drug yet. Browse all trials
PDUFA dates and FDA decisions
| Date as reported | Drug / company | Event | Condition | Evidence |
|---|---|---|---|---|
| 2015-04-17Day | APTENSIO XR | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA205831", "applicant_as_listed_by_fda": "RHODES PHARMS", "brand_names": ["APTENSIO XR"], "active_ingredients": ["METHYLPHENIDATE HYDROCHLORIDE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150417", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |